WES and RNA-seq data of 11 cancer patients with multiple cancer types

This dataset includes WES and RNAseq from 11 patients with metastatic melanoma, lung, kidney, and stomach cancers, enrolled in phase I clinical trials of TIL ACT (NCT03475134 & NCT04643574). WES was performed on matched cancer and healthy samples, whereas RNAseq was performed on cancer tissues, using Illumina HiSeq 2500/4000 and Illumina NextSeq 550 systems. Paired-end reads are provided in fastq format.

36 samples
DAC: EGAC00001003160
Technologies: Illumina HiSeq 2500, Illumina HiSeq 4000, Illumina NovaSeq 6000, NextSeq 550

Access Policy1 Study Files

Metadata

Request Access

Terms and conditions for the data download and usage

If you wish to download the data, please contact the data access committee for the "Data Transfer and Use Agreement" form, which sets the terms and conditions for the data download and usage.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID	Study Title	Study Type
	Cancer sequencing for somatic variant calling	Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID	File Type	Size	Located in